CVS Health Valuation

CVS -- USA Stock  

USD 52.79  0.28  0.53%

CVS Health shows prevailing Real Value of $71.65 per share. The current price of the firm is $52.79. At this time the firm appears to be undervalued. Macroaxis approximates value of CVS Health from analyzing the firm fundamentals such as Profit Margin of (0.08)% and Return On Equity of (0.34)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
Undervalued
May 26, 2019
52.79
Market Value
71.65
Real Value
76.15
Upside
CVS Health is very steady asset. Calculation of real value of CVS Health is based on 2 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

CVS Health Market Cap

CVS Health Corporation is rated third in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 532.36 Billion. CVS Health retains roughly 68.7 Billion in market capitalization claiming about 13% of equities under Health Care Plans industry.
Capitalization  Total debt  Workforce  Valuation  Revenue
Horizon     30 Days    Login   to change
CVS Health Corporation is rated below average in price to book category among related companies. It is rated fifth in last dividend paid category among related companies creating about  1.74  of Last Dividend Paid per Price to Book.

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio0.55
Earnings Quarterly Growth42.40%
Revenue Growth34.40%
Enterprise Value To Ebitda11.42
Earnings Growth11.20%
Enterprise Value To Revenue0.74
Check also Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com